Funds holding IMMUNIC INC
ISIN US4525EP1011 · United States · LEI 549300R5T12FW5MEQB20
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- ≈ 69.4K $ 59K €
A single tracked fund declares this company. So these figures do not say who owns it.
This issuer has other securities: IMMUNIC INC (US4525EP2001)
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 59K € | 0.07 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.07 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 11 | -1 | 7,033,813 | +29.8 % |
| 2026Q1 | 12 | -2 | 5,416,919 | +9.0 % |
| 2025Q4 | 14 | 0 | 4,971,098 | -6.8 % |
| 2025Q3 | 14 | 0 | 5,334,586 | +4.2 % |
| 2025Q2 | 14 | -2 | 5,119,436 | -1.6 % |
| 2025Q1 | 16 | -1 | 5,204,502 | -12.5 % |
| 2024Q4 | 17 | -1 | 5,948,085 | +20.9 % |
| 2024Q3 | 18 | +1 | 4,920,000 | +19.2 % |
| 2024Q2 | 17 | +1 | 4,125,859 | +84.5 % |
| 2024Q1 | 16 | -2 | 2,236,680 | -4.7 % |
| 2023Q4 | 18 | 2,347,562 |
Institutional managers
71 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Aberdeen Group plc | 8,243,941 | 9.2M $ | as of Mar 31, 2026 |
| BVF INC/IL | 7,652,972 | 8.5M $ | as of Mar 31, 2026 |
| Avidity Partners Management LP | 6,699,411 | 7.4M $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 4,500,000 | 5M $ | as of Mar 31, 2026 |
| Laurion Capital Management LP | 3,882,162 | 4.3M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,779,922 | 4.2M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 3,288,540 | 3.7M $ | as of Mar 31, 2026 |
| Nantahala Capital Management, LLC | 2,506,491 | 2.8M $ | as of Mar 31, 2026 |
| 683 Capital Management, LLC | 2,450,000 | 2.7M $ | as of Mar 31, 2026 |
| Propel Bio Management, LLC | 2,344,779 | 2.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,525,769 | 1.7M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,398,600 | 1.6M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,028,256 | 1.1M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 967,152 | 1.1M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 964,230 | 1.1M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 919,164 | 1M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 674,662 | 748.9K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 659,153 | 731.7K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 565,645 | 627.9K $ | as of Mar 31, 2026 |
| UBS Group AG | 522,797 | 580.3K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 493,393 | 547 $ | as of Mar 31, 2026 |
| Simplify Asset Management Inc. | 438,932 | 487.2K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 263,328 | 292.3K $ | as of Mar 31, 2026 |
| Hudson Bay Capital Management LP | 213,017 | 236.4K $ | as of Mar 31, 2026 |
| LPL Financial LLC | 169,300 | 187.9K $ | as of Mar 31, 2026 |
Declared shareholders of IMMUNIC INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| OrbiMed Advisors LLC and 2 others | 5.30 % | 756,860 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding IMMUNIC INC". https://titelia.com/en/stocks/immunic-inc-US4525EP1011